Skip to main content
SpringerLink
Log in
Book cover

Animal Models of Dementia pp 493–513Cite as

Mouse Models of Metachromatic Leukodystrophy and Adrenoleukodystrophy

  • Protocol
  • First Online:

Part of the book series: Neuromethods ((NM,volume 48))

Abstract

Metachromatic leukodystrophy (MLD) and adrenoleukodystrophy (ALD) are two inherited ­leukodystrophies that result in most cases in rapid destruction of the myelin within the central nervous system. There are no spontaneous animal models of these two leukodystrophies and knockout MLD and ALD mice have been generated by homologous recombination into murine embryonic stem cells. The initial analyses of these two mouse models were disappointing as they do not develop overt cerebral demyelination. Further and in-depth analysis has however revealed new and very important insights on the physiopathogenesis of MLD and ALD at an early stage of the disease. These data have now paved the way to new therapeutic approaches.

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Von Figura K, Gieselmann V, Jaeken J (2001) Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) Childs B, Kinzler KW, Vogelstein B (assoc eds) The metabolic and molecular bases of inherited disease, 8th edn. New York: McGraw-Hill, pp 3695–3724

    Google Scholar 

  2. Holtschmidt H, Sandhoff K, Kwon HY, et al. (1991) Sulfatide activator protein: alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. J Biol Chem 266:7556–7560

    PubMed  CAS  Google Scholar 

  3. Gieselmann V, Matzner U, Hess B, et al. (1998) Metachromatic leukodystrophy: molecular genetics and an animal model. J Inherit Metab Dis 21:564–574

    Article  PubMed  CAS  Google Scholar 

  4. Sevin C, Aubourg P, Cartier N (2007) Enzyme, cell and gene-based therapies for metachromatic leukodystrophy. J Inherit Metab Dis 30:175–183

    Article  PubMed  CAS  Google Scholar 

  5. Rauschka H, Colsch B, Baumann N, et al. (2006) Late-onset metachromatic leukody­strophy: genotype strongly influences phenotype. Neurology 67:859–863

    Article  PubMed  CAS  Google Scholar 

  6. Sung Kim T, Kim I-E, Sun Kim W, et al. (1997) MR of childhood metachromatic leukodystrophy. AJNR Am J Neuroradiol 18:733–738

    Google Scholar 

  7. Van der Voorn JP, Pouwels PJ, Kamphorst W, et al. (2005) Histopathologic correlates of radial stripes on MR images in lysosomal ­storage disorders. AJNR Am J Neuroradiol 26:442–446

    PubMed  Google Scholar 

  8. Oguz KK, Anlar B, Senbil N, Cila A (2004) Diffusion-weighted imaging findings in juvenile metachromatic leukodystrophy. Neurope­diatrics 35:279–282

    Article  PubMed  CAS  Google Scholar 

  9. Gieselmann V, Zlotogora J, Harris A, Wenger DA, Morris CP (1994) Molecular genetics of metachromatic leukodystrophy. Hum Mutat 1994:233–242

    Google Scholar 

  10. Biffi A, Cesani M, Fumagalli F, et al. (2008) Metachromatic leukodystrophy – mutation analysis provides further evidence of genotype-phenotype correlation. Clin Genet 74:349–357

    Article  PubMed  CAS  Google Scholar 

  11. Hess B, Saftig P, Hartmann D, et al. (1996) Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc Natl Acad Sci U S A 93:14821–14826

    Article  PubMed  CAS  Google Scholar 

  12. Sevin C, Benraiss A, Van Dam D, et al. (2006) Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy. Hum Mol Genet 15:53–64

    Article  PubMed  CAS  Google Scholar 

  13. Sevin C, Verot L, Benraiss A, et al. (2007) Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Gene Ther 14:405–414

    Article  PubMed  CAS  Google Scholar 

  14. Wittke D, Hartmann D, Gieselmann V, Lüllmann-Rauch R (2004) Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution. Acta Neuropathol 108:261–271

    Article  PubMed  CAS  Google Scholar 

  15. Yaghootfam A, Gieselmann V, Eckhardt M (2005) Delay of myelin formation in arylsulphatase A-deficient mice. Eur J Neurosci 21:711–720

    Article  PubMed  Google Scholar 

  16. Givogri MI, Bottai D, Zhu HL, et al. (2008) Multipotential neural precursors transplanted into the metachromatic leukodystrophy brain fail to generate oligodendrocytes but contribute to limit brain dysfunction. Dev Neurosci 30:340–357

    Article  PubMed  CAS  Google Scholar 

  17. D’Hooge R, Hartmann D, Manil J, et al. (1999) Neuromotor alterations and cerebellar deficits in aged arylsulfatase A-deficient transgenic mice. Neurosci Lett 273:93–96

    Article  PubMed  Google Scholar 

  18. D’Hooge R, Coenen R, Gieselmann V, Lüllmann-Rauch R, De Deyn PP (1999) Decline in brainstem auditory-evoked potentials coincides with loss of spiral ganglion cells in arylsulfatase A-deficient mice. Brain Res 847:352–356

    Article  PubMed  Google Scholar 

  19. Coenen R, Gieselmann V, Lüllmann-Rauch R (2001) Morphological alterations in the inner ear of the arylsulfatase A-deficient mouse. Acta Neuropathol 101:491–498

    PubMed  CAS  Google Scholar 

  20. Biffi A, De Palma M, Quattrini A, et al. (2004) Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J Clin Invest 113:1118–1129

    PubMed  CAS  Google Scholar 

  21. Schott I, Hartmann D, Gieselmann V, Lüllmann-Rauch R (2001) Sulfatide storage in visceral organs of arylsulfatase A-deficient mice. Virchows Arch 439:90–96

    Article  PubMed  CAS  Google Scholar 

  22. D’Hooge R, Van Dam D, Franck F, Gieselmann V, De Deyn PP (2001) Hyperac­tivity, neuromotor defects, and impaired learning and memory in a mouse model for metachromatic leukodystrophy. Brain Res 907:35–43

    Article  PubMed  Google Scholar 

  23. Stroobants S, Leroy T, Eckhardt M, et al. (2008) Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy. Behav Brain Res 189:306–316

    Article  PubMed  CAS  Google Scholar 

  24. Saravanan K, Schaeren-Wiemers N, Klein D, et al. (2004) Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder. Neurobiol Dis 16:396–406

    Article  PubMed  CAS  Google Scholar 

  25. Griffiths I, Klugmann M, Anderson T, et al. (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610–1613

    Article  PubMed  CAS  Google Scholar 

  26. Lappe-Siefke C, Goebbels S, Gravel M, et al. (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366–374

    Article  PubMed  CAS  Google Scholar 

  27. Eckhardt M, Hedayati KK, Pitsch J, et al. (2007) Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy. J Neurosci 27:9009–9021

    Article  PubMed  CAS  Google Scholar 

  28. Ramakrishnan H, Hedayati KK, Lüllmann-Rauch R, et al. (2007) Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy. J Neurosci 27:9482–9490

    Article  PubMed  CAS  Google Scholar 

  29. Matzner U, Matthes F, Herbst E, et al. (2007) Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy. Mol Med 13:471–479

    Article  PubMed  CAS  Google Scholar 

  30. Matzner U, Lüllmann-Rauch R, Stroobants S, et al. (2009) Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy. Mol Ther 17(4):600–606

    Article  PubMed  CAS  Google Scholar 

  31. Eckhardt M (2008) The role and metabolism of sulfatide in the nervous system. Mol Neurobiol 37:93–103

    Article  PubMed  CAS  Google Scholar 

  32. Molander-Melin M, Pernber Z, Franken S, et al.(2004) Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice. J Neurocytol 33:417–427

    Article  PubMed  CAS  Google Scholar 

  33. Lutjohann D, Harzer K, Gieselmann V, Eckhardt M (2006) Reduced brain cholesterol content in arylsulfatase A-deficient mice. Biochem Biophys Res Commun 34:647–650

    Article  Google Scholar 

  34. Jeon SB, Yoon HJ, Park SH, Kim IH, Park EJ (2008) Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol 181:8077–8087

    PubMed  CAS  Google Scholar 

  35. Mosser J, Douar AM, Sarde CO, et al. (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726–730

    Article  PubMed  CAS  Google Scholar 

  36. Dubois-Dalcq M, Feigenbaum V, Aubourg P (1999) The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci 22:4–12

    Article  PubMed  CAS  Google Scholar 

  37. Moser HW, Mahmood A, Raymond GV X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 3:140–151

    Google Scholar 

  38. Ito M, Blumberg BM, Mock DJ, et al. (2001) Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 60:1004–1019

    PubMed  CAS  Google Scholar 

  39. Powers JM, DeCiero DP, Ito M, Moser AB, Moser HW (2000) Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol 5989–6102

    Google Scholar 

  40. Fouquet F, Zhou JM, Ralston E, et al. (1997) Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system. Neurobiol Dis 3:271–285

    Article  PubMed  CAS  Google Scholar 

  41. Höftberger R, Kunze M, Weinhofer I, et al. (2007) Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy. Neurobiol Dis 28:165–174

    Article  PubMed  Google Scholar 

  42. Kemp S, Wanders RJ (2007) X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 9:268–276

    Article  Google Scholar 

  43. Liu LX, Janvier K, Berteaux-Lecellier V, et al. (1999) Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters. J Biol Chem 274:32738–32743

    Article  PubMed  CAS  Google Scholar 

  44. Guimarães CP, Domingues P, Aubourg P, et al. (2004) Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo. Biochim Biophys Acta 1689:235–243

    PubMed  Google Scholar 

  45. Van Roermund CW, Visser WF, Ijlst L, et al. (2008) The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J 22:4201–4208

    Article  PubMed  CAS  Google Scholar 

  46. Forss-Petter S, Werner H, Berger J, et al. (1997) Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice. J Neurosci Res 50:829–843

    Article  PubMed  CAS  Google Scholar 

  47. Lu JF, Lawler AM, Watkins PA, et al. (1997) A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci U S A 94:9366–9371

    Article  PubMed  CAS  Google Scholar 

  48. Pujol A, Hindelang C, Callizot N, et al. (2002) Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum Mol Genet 11:499–505

    Article  PubMed  CAS  Google Scholar 

  49. Pujol A, Ferrer I, Camps C, et al. (2004) Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum Mol Genet 13:2997–3006

    Article  PubMed  CAS  Google Scholar 

  50. Fourcade S, López-Erauskin J, Galino J, et al. (2008) Early oxidative damage underlying neurodegeneration in X-adrenoleukodystro­phy. Hum Mol Genet 17:1762–1773

    Article  PubMed  CAS  Google Scholar 

  51. Dumser M, Bauer J, Lassmann H, Berger J, Forss-Petter S (2007) Lack of adrenoleukod­ystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency. Acta Neuropathol 114:573–586

    Article  PubMed  CAS  Google Scholar 

  52. Ferrer I, Kapfhammer JP, Hindelang C, et al. (2005) Inactivation of the peroxisomal ABCD2 transporter in the mouse leads to late-onset ataxia involving mitochondria, Golgi and ­endoplasmic reticulum damage. Hum Mol Genet 14:3565–3577

    Article  PubMed  CAS  Google Scholar 

  53. Flavigny E, Sanhaj A, Aubourg P, Cartier N (1999) Retroviral-mediated adrenoleukodystr­ophy-related gene transfer corrects very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts: implications for therapy. FEBS Lett 448:261–264

    Article  PubMed  CAS  Google Scholar 

  54. Fourcade S, Ruiz M, Camps C, et al. (2009) A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am J Physiol Endocrinol Metab 296:E211–E221

    Article  PubMed  CAS  Google Scholar 

  55. Dringen R, Gutterer JM, Hirrlinger J (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 267:4912–4916

    Article  PubMed  CAS  Google Scholar 

  56. Khan M, Singh J, Singh I (2008) Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. J Neurochem 106:1766–1779

    PubMed  CAS  Google Scholar 

  57. Kemp S, Valianpour F, Denis S, et al. (2005) Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy. Mol Genet Metab 84:144–151

    Article  PubMed  CAS  Google Scholar 

  58. Platta HW, El Magraoui F, Schlee D, et al. (2007) Ubiquitination of the peroxisomal import receptor Pex5p is required for its recycling. J Cell Biol 177:197–204

    Article  PubMed  CAS  Google Scholar 

  59. Baes M, Gressens P, Baumgart E, et al. (1997) A mouse model for Zellweger syndrome. Nat Genet 17:49–57

    Article  PubMed  CAS  Google Scholar 

  60. Gould SJ, Valle D (2000) Peroxisome biogenesis disorders: genetics and cell biology. Trends Genet 16:340–345

    Article  PubMed  CAS  Google Scholar 

  61. Kassmann CM, Lappe-Siefke C, Baes M, et al. (2007) Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 39:969–976

    Article  PubMed  CAS  Google Scholar 

  62. Wanders RJ, Waterham HR (2006) Peroxisomal disorders: the single peroxisomal enzyme deficiencies. Biochim Biophys Acta 1763:1707–1720

    Article  PubMed  CAS  Google Scholar 

  63. Purdue PE, Zhang JW, Skoneczny M, Lazarow PB (1997) Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat Genet 15:381–384

    Article  PubMed  CAS  Google Scholar 

  64. Brites P, Mooyer PA, El Mrabet L, Waterham HR, Wanders RJ (2009) Plasmalogens participate in very-long-chain fatty acid-induced pathology. Brain 132:482–492

    Article  PubMed  Google Scholar 

  65. Moody DB, Zajonc DM, Wilson IA (2005) Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol 5:387–399

    Article  PubMed  CAS  Google Scholar 

  66. Young DC, Moody DB (2006) T-cell recognition of glycolipids presented by CD1 ­proteins. Glycobiology 16:103R–112R

    Article  PubMed  CAS  Google Scholar 

  67. Moody DB (2006) TLR gateways to CD1 function. Nat Immunol 7:811–817

    Article  PubMed  CAS  Google Scholar 

  68. Cheng TY, Relloso M, Van Rhijn I, et al. (2006) Role of lipid trimming and CD1 groove size in cellular antigen presentation. EMBO J 25:2989–2999

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculté des Sciences Pharmaceutiques et Biologiques-Paris5, INSERM UMR745 and Paris-Descartes University, Paris, France

    Patrick Aubourg, Caroline Sevin & Nathalie Cartier

Authors
  1. Patrick Aubourg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline Sevin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nathalie Cartier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute Born-Bunge, Lab of Neurochemistry & Behaviour, University of Antwerp, Universiteitsplein 1, Wilrijk, 2610, Belgium

    Peter Paul De Deyn

  2. Institute Born-Bunge, Lab of Neurochemistry & Behaviour, University of Antwerp, Universiteitsplein 1, Wilrijk, 2610, Belgium

    Debby Van Dam

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Aubourg, P., Sevin, C., Cartier, N. (2011). Mouse Models of Metachromatic Leukodystrophy and Adrenoleukodystrophy. In: De Deyn, P., Van Dam, D. (eds) Animal Models of Dementia. Neuromethods, vol 48. Humana Press. https://doi.org/10.1007/978-1-60761-898-0_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-898-0_26

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-897-3

  • Online ISBN: 978-1-60761-898-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation